Preexposure prophylaxis (PrEP) is underused in persons who use drugs and justice-
involved persons. In an ongoing randomized controlled trial in 4 US locations comparing …

Background Standards of care for pregnant persons with opioid use disorder (OUD) have
been published across multiple institutions specializing in obstetrics and addiction medicine …

Background Opioid overdose continues to be a major cause of death in the United States.
One effort to control opioid use has been to implement policies that enhance criminalization …

Importance Agonist medications for opioid use disorder (MOUD), buprenorphine and
methadone, in carceral settings might reduce the risk of postrelease opioid overdose but are …

The association between recent release from incarceration and dramatically increased risk
of fatal overdose is well-established at the individual level. Fatal overdose and …

History of incarceration is associated with an excess of morbidity and mortality. While the
incarceration experience itself comes with substantive health risks (eg, injury, psychological …

Abstract Background Overdose prevention centers (OPCs) are being implemented in the
United States as a strategy to reduce drug-related mortality and morbidity. Previous studies …

Background Adults with co-occurring opioid use and mental health disorder (COD) recently
released from incarceration have many social and health needs that place them at the most …

Background Implementation of medications for opioid use disorder (MOUD) in jails varies by
facility and across states. Organizational climate, including staff attitudes toward change and …

Objectives Little is known about the correlates of use of medications to treat opioid use
disorder (MOUD, ie, buprenorphine, methadone, naltrexone) offered in jails. We evaluated …